Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06046014 · ClinicalTrials.gov registry record · NA
Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors
A NA study of Body Image and Young Adult Cancer, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06046014: Completed NA study of Body Image and Young Adult Cancer, sponsored by University of Michigan Rogel Cancer Center.
NCT06046014 is a NA study of Body Image and Young Adult Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 30 participants, below the 311-participant average among 8 other Body Image trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06046014, a NA study of Body Image and Young Adult Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Each year, about 89,500 adolescents and young adults (AYAs; 15-39 years old) are diagnosed with cancer and up to 60% experience body image (BI) distress. BI is largely developed in adolescence and young adulthood and has implications for self-identity and quality of life. Cancer itself and its associated treatments precipitate changes to appearance as well as body sensation and function, all of which can alter BI and lead to increased anxiety. An in-home BI-focused expressive writing (EW) program offers a promising outlet for addressing BI distress and anxiety in a way that eliminates constraints of clinical time and specialist availability. There are no recommended interventions to help AYA cancer survivors cope with BI distress. To address this knowledge gap, the objective of this this pilot randomized-controlled trial is to determine the feasibility of a four-week BI-focused EW intervention to decrease BI distress and anxiety among AYA cancer survivors with the hypothesis that this intervention will reduce BI distress and anxiety.
Primary Outcome
percent of patients recruited within 6 months
Conditions Studied
Interventions
- OTHER Control
- OTHER BI Focused writing
Study Locations (1)
Michigan
- University of Michigan Rogel Cancer Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-09-14 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
What the finished NCT06046014 record still lists
NCT06046014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 311-participant average among 8 other Body Image trials with a reported enrollment target (90% lower).
The record links to 3 conditions, with Body Image appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT06046014 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06046014 about?
NCT06046014 is a clinical study titled "Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors". Each year, about 89,500 adolescents and young adults (AYAs; 15-39 years old) are diagnosed with cancer and up to 60% experience body image (BI) distress. BI is largely developed in adolescence and young adulthood and has implications for self-identity and quality of life. Cancer itself and its assoc...
What is the current status of trial NCT06046014?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2024-09-14. Estimated completion is 2025-06-01.
What conditions does trial NCT06046014 study?
This clinical trial studies the following conditions: Body Image, Young Adult Cancer, Adolescent Cancer.
What interventions are being tested in trial NCT06046014?
The interventions under investigation include: Control (OTHER), BI Focused writing (OTHER).
Who is sponsoring clinical trial NCT06046014?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06046014 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Image
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06046014's enrollment target sits among peer trials
30 8th of 8 higher than 1 of 8 other Body Image trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Body Image trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
RECRUITING · NA
-
The Impact of a Podcast-based Body Image Intervention Among Millennial Women
RECRUITING · NA
-
WISH, Feasibility of a Factorial Design
ACTIVE NOT RECRUITING · NA
-
A Single Session Community-Based Body Empowerment Session
ACTIVE NOT RECRUITING · NA
-
The Effects of Yoga on Body Image in College Women
COMPLETED · NA
-
Targeting Body Image Among Women of Higher Body Weight
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI